Jun 24 |
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
|
Jun 19 |
Nurix Therapeutics (NRIX) Surges 20.6%: Is This an Indication of Further Gains?
|
Jun 18 |
Raymond James starts Omega at outperform, cites platform
|
May 30 |
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
|
May 29 |
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
|
May 8 |
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
|
May 7 |
4 Analysts Have This To Say About Omega Therapeutics
|
May 7 |
Omega Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
|
May 6 |
Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Tops Revenue Estimates
|
May 6 |
Omega Therapeutics GAAP EPS of -$0.36, revenue of $2.36M
|